AGTR1 and triple-A syndrome: These results are not only consistent with recently published data showing reduced AAA formation in β-arrestin-2–/– mice upon AngII stimulation,63 but also delineate a landscape in depth with its clinical relevance, in vivo regulatory mechanism, detailed structural basis and pharmacological characterization of biased AT1 signaling regulated by COMP, an endogenous biased modulator.